Immune Response News and Research

RSS

Intrauterine devices (IUDs) may lower risk of cervical cancer

According to a recent study, intrauterine devices (IUDs) used by women for contraception might lower the risk of getting cervix cancer compared to women who do not use this form of contraception. The review titled, “Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis” from the Keck School of Medicine of USC appeared in the online November issue of Obstetrics & Gynecology.

8 Nov 2017

Scientists uncover previously unknown mechanism to combat influenza A virus

Just as flu season swings into full gear, researchers from the University of Colorado Boulder and University of Texas at Austin have uncovered a previously unknown mechanism by which the human immune system tries to battle the influenza A virus.

8 Nov 2017

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

In its latest pioneering effort to harness the power of focused ultrasound to battle disease, the University of Virginia Health System is examining the scalpel-free surgery's potential to enable the body to identify and destroy metastatic breast cancer cells.

8 Nov 2017

IUD use linked to dramatic decrease in incidence of cervical cancer

Considered a safe and highly effective contraception method, intrauterine devices (IUDs) may also be quietly offering protection against the third-most common cancer in women worldwide.

8 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Stem cells could help improve blood circulation in diabetic patients with peripheral artery disease

Stem cells taken from muscle tissue could promote better blood flow in patients with diabetes who develop peripheral artery disease, a painful complication that can require surgery or lead to amputation.

7 Nov 2017

New study finds enhanced impact of drug combination for FAP patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care.

7 Nov 2017

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Research at the Southwest National Primate Research Center on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.

7 Nov 2017

Study reveals role of specific lipids in accelerating or curbing bacterial infection

Lipids appear to play an important role in infections. According to researchers from the University of Maastricht in Maastricht, The Netherlands, and the University of Maryland, Baltimore (UMB) in Baltimore, Md., USA, specific lipids can greatly accelerate bacterial infection.

7 Nov 2017

New study shows link between gut bacteria and age-related chronic inflammation

A new study shows for the first time that gut bacteria from old mice induce age-related chronic inflammation when transplanted into young mice.

3 Nov 2017

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

A collaborative research and development partnership between researchers at the University of Georgia and Sanofi Pasteur, the largest influenza vaccine manufacturer in the world, has resulted in the identification of a vaccine candidate that protects against multiple co-circulating strains of H3N2 influenza isolated over five seasons following testing in mouse and ferret models.

2 Nov 2017

First-of-its-kind nonsynthetic, decellularized graft one step closer to clinical trials

Researchers at the University of Minnesota have created a new lab-grown blood vessel replacement that is composed completely of biological materials, but surprisingly doesn't contain any living cells at implantation. The vessel, that could be used as an "off the shelf" graft for kidney dialysis patients, performed well in a recent study with nonhuman primates.

1 Nov 2017

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection.

31 Oct 2017

Stem cells do not participate directly in cartilage regeneration but serve to ‘animate’ the process

Stem cell therapy has great potential for curing cartilage damage. However, it has remained unclear whether stem cells are responsible for regeneration or whether they trigger the process.

31 Oct 2017

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.

31 Oct 2017

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced it has initiated a Phase I study assessing the intratumoral application of its novel RNAdjuvant technology in patients with superficial solid tumors that are easily accessible for repeated intratumoral injections. RNAdjuvant is designed to amplify the scope and quality of an immune response when used alone or in combination with other immune therapies.

28 Oct 2017

Longevity Biotech receives award to evaluate novel drug candidate for MS in preclinical models

Longevity Biotech, Inc. has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial research funding program, to evaluate LBT-3627 in preclinical models as a potential disease-modifying therapeutic agent.

28 Oct 2017

University of Colorado’s second shingles vaccine approved by FDA

The Centers for Disease Control's Advisory Committee on Immunization Practices recommended new treatment practices Wednesday for shingles based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus.

28 Oct 2017

Novel molecule holds potential to become part of successful HIV vaccine

Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.

27 Oct 2017

AACI, CDC, and ACS honor pediatricians who adopt effective HPV vaccination practices

Today the Association of American Cancer Institutes, the American Cancer Society, Inc., and the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases announced 10 award winners as part of its HPV Vaccine Is Cancer Prevention campaign.

27 Oct 2017

Immune Response News and Research

Intrauterine devices (IUDs) may lower risk of cervical cancer

Scientists uncover previously unknown mechanism to combat influenza A virus

UVA examines scalpel-free surgery's potential to help the body destroy breast cancer cells

IUD use linked to dramatic decrease in incidence of cervical cancer

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Stem cells could help improve blood circulation in diabetic patients with peripheral artery disease

New study finds enhanced impact of drug combination for FAP patients

Texas Biomedical Research Institute tests promising new treatment for HBV infection

Study reveals role of specific lipids in accelerating or curbing bacterial infection

New study shows link between gut bacteria and age-related chronic inflammation

Collaborative research identifies broadly cross-protective vaccines for H3N2 influenza

First-of-its-kind nonsynthetic, decellularized graft one step closer to clinical trials

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

Stem cells do not participate directly in cartilage regeneration but serve to ‘animate’ the process

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

CureVac begins phase I study to assess intratumoral application of RNAdjuvant technology in patients with solid tumors

Longevity Biotech receives award to evaluate novel drug candidate for MS in preclinical models

University of Colorado’s second shingles vaccine approved by FDA

Novel molecule holds potential to become part of successful HIV vaccine

AACI, CDC, and ACS honor pediatricians who adopt effective HPV vaccination practices

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News